Mira Dx Licenses miRNA Technology for Breast Cancer from Yale

The technology identifies microRNA disrupting variants in and around the BRCA1 gene that are polymorphic in breast cancer populations.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.